Guylène Rignol Selected Research

Achondroplasia

1/2020

In vitro and in vivo characterization of Recifercept, a soluble fibroblast growth factor receptor 3, as treatment for achondroplasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Guylène Rignol Research Topics

Disease

2	Lung Neoplasms (Lung Cancer) 11/2023 - 01/2023
1	Adenocarcinoma of Lung 01/2023
1	Neoplasms (Cancer) 01/2023
1	Achondroplasia 01/2020
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2020
1	Atherosclerosis 10/2015

Drug/Important Bio-Agent (IBA)

1	Proto-Oncogene Proteins c-metIBA 11/2023
1	CyclodextrinsIBA 01/2023
1	CholesterolIBA 01/2023
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Type 3 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 3)IBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 10/2015

Therapy/Procedure

1	Therapeutics 01/2023